Viewing Study NCT04472767

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-06-18 @ 3:59 PM
Study NCT ID: NCT04472767
Status: RECRUITING
Last Update Posted: 2025-04-30
First Post: 2020-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
Sponsor: University of California, Irvine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
None HCC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular Carcinoma View
None HCC View
None Cabozantinib View
None Ipilimumab View
None Nivolumab View
None TACE View
None transarterial chemoembolization View